FDA Grants Millennium's MLN341 and MLN518 Fast Track Status

Topics:
Healthcare Services,
Pharmeceuticals
Tags:
FDA,
Federal Government,
Government,
Healthcare,
Millennium Pharmaceuticals Inc.,
MLN341
Source:
Millennium Pharmaceuticals

FREE Registration is required

Overview: This article encapsulates and gives details about Millennium Pharmaceuticals. Millennium Pharmaceuticals is a leading biopharmaceutical company, applies its comprehensive and integrated science and technology platform for the discovery and development of breakthrough therapeutic and predictive medicine products with a goal of delivering personalized medicine. Millennium Pharmaceuticals informs that the Food and Drug Administration (FDA) has awarded cancer therapies, MLN341 (formerly known as LDP341 and PS341) and MLN518 (formerly known as CT53518) Fast Track designation. MLN341 is currently in Phase III clinical trials for the treatment of relapsed and refractory multiple myeloma, and MLN518 is currently in Phase I clinical trials for the treatment of acute myeloid leukemia (AML).

(Is this item miscategorized? Does it need more tags? Let us know.)

Format: HTML | Date: Jun 2002 | Pages: 4

People who downloaded this item also downloaded

White Paper Product Development: Challenges And Recommendations

Top results from Healthcare Services

Resource Center Protect your patient data and your budget at the same time
White Paper New HIPPA Regulations Require Quick Action By Group Health Plans
White Paper A Common Language Architecture for Health Care
White Paper A Digital Imaging Transformation in Radiology Departments
White Paper Alternative Health Care Models

» View all Healthcare Services listings

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Returning users: Log In Here!

Already registered on BNET, TechRepublic, or ZDNet? Simply log in.

Free Membership: Sign Up Now!

Sign up for a free membership today and get instant and unlimited access to one of the largest databases of white papers, webcasts, and casestudies anywhere. Your FREE membership allows you to:

  • Download an unlimited amount of content, including classic and current white papers, case studies, webcasts and more
  • Track content on your chosen topics of interest
  • Receive targeted email alerts when your favorite content is added
  • Save content for future reading
  • Receive our member newsletter

When you register to access this directory, you become a member of BNET. In addition, you allow us to share your information with companies that produce products or services featured in the library--so that such companies may contact you with information and offers regarding their products and services. This enables us to keep the library a free service. As a directory registrant, you will receive a complimentary subscription to the BNET member newsletter, The BNET Report. You can unsubscribe from this newsletter at any time. By clicking the Sign up button, you indicate that you agree to our Terms and Conditions and have read and understand our Privacy Policy (updated).